Will Tesla Stock Go Up In 2026?
EV giant Tesla (NASDAQ:TSLA) has, somewhat surprisingly, undershot the broader…
Sell
37
NMRA Quote, Financials, Valuation and Earnings
Last price:
$1.96
Seasonality move
:
-24.63%
Day range:
$1.97 - $2.12
52-week range:
$0.61 - $11.57
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
2.64x
Volume:
618.4K
Avg. volume:
1.3M
1-year change:
-80.25%
Market cap:
$349.2M
Revenue:
--
EPS (TTM):
-$1.46
Earnings Data
Next earnings date for NMRA
Mar 02
2026
Most recent earnings per share
-$0.35
Missed by $0.02
(Nov 6/2025)
Consensus Estimate
-$0.34
(Nov 6/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
NMRA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/02/2026 | Q4 | -- | -- | -- | -$0.33 | -- |
| 11/06/2025 | Q3 | -- | -- | -$0.35 | -$0.34 | -$0.02 |
| 08/06/2025 | Q2 | -- | -- | -$0.33 | -$0.37 | $0.04 |
| 05/12/2025 | Q1 | -- | -- | -$0.42 | -$0.38 | -$0.04 |
| 03/03/2025 | Q4 | -- | -- | -$0.37 | -$0.44 | $0.08 |
| 11/12/2024 | Q3 | -- | -- | -$0.45 | -$0.38 | -$0.07 |
| 08/06/2024 | Q2 | -- | -- | -$0.37 | -$0.36 | -$0.01 |
| 05/07/2024 | Q1 | -- | -- | -$0.34 | -$0.32 | -$0.02 |
| 03/07/2024 | Q4 | -- | -- | -$0.68 | -$0.60 | -$0.08 |
| 11/01/2023 | Q3 | -- | -- | -$0.35 | -$0.43 | $0.08 |
| 06/30/2023 | Q2 | -- | -- | -$0.25 | -- | -- |
| 03/31/2023 | Q1 | -- | -- | -$0.23 | -- | -- |
| 12/31/2022 | Q4 | -- | -- | -$0.19 | -- | -- |
| 09/30/2022 | Q3 | -- | -- | -$0.19 | -- | -- |
| 06/30/2022 | Q2 | -- | -- | -$0.20 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$0.28 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | -$0.18 | -- | -- |
| 09/30/2021 | Q3 | -- | -- | -$1.17 | -- | -- |
| 06/30/2021 | Q2 | -- | -- | -$0.11 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$0.10 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$0.13 | -- | -- |
Neumora Therapeutics, Inc. Earnings Questions
-
How Much did Neumora Therapeutics, Inc. Generate in Revenue Last Quarter?
Neumora Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.
-
Did Neumora Therapeutics, Inc. Beat Earnings Last Quarter?
Neumora Therapeutics, Inc. announced earnings per share of -$0.35 which represents a miss of analyst forecast a -$0.34 per share.
-
Is Neumora Therapeutics, Inc. Profitable?
Neumora Therapeutics, Inc. reported -$23K that represents -$0.00 per share over the last quarter.
-
What is the Analyst Consensus for Neumora Therapeutics, Inc. EPS Next Year?
Neumora Therapeutics, Inc.'s earnings are forecast to decrease from -$1.53 per share to -$1.60 per share next year representing a decrease of -6.48%.
-
When is Neumora Therapeutics, Inc.'s Earnings Date?
Neumora Therapeutics, Inc.'s next earnings date is March 2, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
What Are the Best AI Power Stocks?
As the construction of AI infrastructure accelerates, the gap between…
Is IONQ The Best Quantum Stock to Buy?
Riding a wave of investor enthusiasm for the technology, quantum…
Stock Ideas
Sell
47
Is NVDA Stock a Buy?
Market Cap: $4.3T
P/E Ratio: 60x
Buy
58
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
73
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 39x
Alerts
Buy
80
FEIM alert for Dec 15
Frequency Electronics, Inc. [FEIM] is down 3.51% over the past day.
Buy
57
MOD alert for Dec 15
Modine Manufacturing Co. [MOD] is up 1.79% over the past day.
Sell
42
OKLO alert for Dec 15
Oklo, Inc. [OKLO] is down 5.81% over the past day.
